Thursday, November 19, 2009

FARESTON

Protected by Copyscape Plagiarism Checking Tool

Toremifene is available with the generic name Fareston and is mostly prescribed for the treatment of metastatic breast cancer in women who have passed their menopausal period or those having estrogen-receptor–positive or unidentified tumors. The effects of Fareston bodybuilding and fareston prostate cancer reduction uses are also largely known. Fareston (toremifene) works by preventing estrogen-induced stimulation of DNA production, thereby controlling the formation and growth of cancerous cells that may develop into breast cancer. 60 mg of fareston dosage is taken once in a day as directed to the patients suffering from breast cancer according to the fareston prescription information. Fareston not only helps in controlling the growth of cancer cells, but also makes it to shrink in size and prevent it from spreading to other parts of the body.
Toremifene when used along with other medicines can lead to serious complications. Using this drug with nicoumalone and warfarin can lead to blood thinning so that increased risk of bleeding takes place. The use of antiepileptics carbamazepine, phenytoin, phenobarbital etc with toremifene paves way for reduced levels of this drug in the blood. Using thiazide diuretics with toremifene should also be avoided to prevent the risk for hypercalcaemia. Pregnant women or breastfeeding mothers are advised to avoid using Fareston. The use of alcohol, nicotine and caffeine should also be limited to reduce the side effects of using Fareston like hot flashes and sweating.
There are so many possible side effects reported with the usage of this drug that includes: headache, skin pigmentation, fatigue, weight gain, hypercalcaemia, dizziness, nausea, abnormal vaginal bleeding, oedema, vaginal discharge (leucorrhoea), pain etc. You can purchase this drug online through registered websites or by logging on to Fareston buy account provided online. However, remember to check fareston label for authenticity.

1 comment: